Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 177 entries
View as:

Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00250679 Org: User:
Start: 10/31/05 End: 10/31/07 Due: 10/31/08

To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00064415 Org: User:
Start: 06/30/02 End: 12/31/04 Due: 12/31/05

PEARL Schizophrenia Maintenance

Phase: N/A Priority: Normal
NCT ID: NCT01435928 Org: User:
Start: 09/30/11 End: 08/31/13 Due: 08/31/14

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00691405 Org: User:
Start: 10/31/03 End: 05/31/04 Due: 05/31/05

A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes

Phase: N/A Priority: Normal
NCT ID: NCT03292016 Org: User:
Start: 08/22/17 End: 03/05/19 Due: 03/05/20

Dasotraline Pediatric Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT02457819 Org: User:
Start: 06/30/15 End: 02/02/17 Due: 02/02/18

Digoxin Drug-Drug Interaction With Lurasidone HCl

Phase: N/A Priority: Normal
NCT ID: NCT01082289 Org: User:
Start: 09/30/08 End: 10/31/08 Due: 10/31/09

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Phase: N/A Priority: Normal
NCT ID: NCT00268723 Org: User:
Start: 12/31/05 End: 02/28/06 Due: 02/28/07

A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02178956 Org: User:
Start: 10/31/14 End: 09/20/17 Due: 09/20/18

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04988555 Org: User:
Start: 02/28/22 End: 10/31/27 Due: 10/31/28

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Phase: N/A Priority: Normal
NCT ID: NCT01074632 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

Study of DSP-0390 in Patients with Recurrent High-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT05023551 Org: User:
Start: 09/08/21 End: 10/31/26 Due: 10/31/27

RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE

Phase: N/A Priority: Normal
NCT ID: NCT01082146 Org: User:
Start: 08/31/08 End: 08/31/08 Due: 08/31/09

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03604783 Org: User:
Start: 12/26/18 End: 01/10/24 Due: 01/10/25

Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654

Phase: N/A Priority: Normal
NCT ID: NCT06389955 Org: User:
Start: 05/22/23 End: 08/24/23 Due: 08/24/24

Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00615433 Org: User:
Start: 01/31/08 End: 01/31/10 Due: 01/31/11

Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01042106 Org: User:
Start: 11/30/09 End: 07/31/10 Due: 07/31/11

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Phase: N/A Priority: Normal
NCT ID: NCT03231800 Org: User:
Start: 07/31/17 End: 03/15/19 Due: 03/15/20

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)

Phase: N/A Priority: Normal
NCT ID: NCT01458275 Org: User:
Start: 11/30/11 End: 03/31/13 Due: 03/31/14

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

Phase: N/A Priority: Normal
NCT ID: NCT01143077 Org: User:
Start: 06/30/10 End: 05/31/11 Due: 05/31/12

Dasotraline Pediatric ADHD Study

Phase: N/A Priority: Normal
NCT ID: NCT02428088 Org: User:
Start: 04/30/15 End: 07/31/16 Due: 07/31/17

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00386334 Org: User:
Start: 10/31/06 End: 02/29/08 Due: 02/28/09

Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00368160 Org: User:
Start: 03/31/04 End: 07/31/05 Due: 07/31/06

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00549718 Org: User:
Start: 10/31/07 End: 10/31/10 Due: 10/31/11

A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03311334 Org: User:
Start: 12/14/17 End: 11/29/22 Due: 11/29/23